/
Musculoskeletal
Ankylosing Spondylitis
17
Pipeline Programs↗
17
Active Trials↗
32
Companies Involved↗
Ankylosing Spondylitis is an emerging landscape with 17 programs across 32 companies. The most active players are Hunan Kelun Pharmaceutical Co., Ltd., Jiangsu vcare pharmaceutical technology co., LTD, Lynk Pharmaceuticals Co., Ltd. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical15
Phase 1
No programs
Phase 2
No programs
Approved
No programs
Analysis
Trial Status
187
clinical trials
Completed131 · 70%
Unknown status23 · 12%
Terminated11 · 6%
Recruiting8 · 4%
Not yet recruiting6 · 3%
Withdrawn5 · 3%
Other3 · 2%
Clinical Trials
Trial Activity
187 trials
Effects of Posture-Focused Exercises on Spinal Alignment in Patients With Ankylosing Spondylitis: A Rasterstereographic Evaluation-Based Randomized Controlled Trial
Not yet recruiting·—·Preclinical·NCT07879157·54 enrolled
Page 1 of 13
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)